These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 14622259)

  • 1. Interaction of the C1 complex of complement with sulfated polysaccharide and DNA probed by single molecule fluorescence microscopy.
    Tissot B; Daniel R; Place C
    Eur J Biochem; 2003 Dec; 270(23):4714-20. PubMed ID: 14622259
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mass spectrometry analysis of the oligomeric C1q protein reveals the B chain as the target of trypsin cleavage and interaction with fucoidan.
    Tissot B; Gonnet F; Iborra A; Berthou C; Thielens N; Arlaud GJ; Daniel R
    Biochemistry; 2005 Feb; 44(7):2602-9. PubMed ID: 15709773
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interaction of fucoidan with the proteins of the complement classical pathway.
    Tissot B; Montdargent B; Chevolot L; Varenne A; Descroix S; Gareil P; Daniel R
    Biochim Biophys Acta; 2003 Sep; 1651(1-2):5-16. PubMed ID: 14499584
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of C1.
    Colomb MG; Arlaud GJ; Villiers CL
    Philos Trans R Soc Lond B Biol Sci; 1984 Sep; 306(1129):283-92. PubMed ID: 6149573
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of human complement serine-proteinase C1r is down-regulated by a Ca(2+)-dependent intramolecular control that is released in the C1 complex through a signal transmitted by C1q.
    Thielens NM; Illy C; Bally IM; Arlaud GJ
    Biochem J; 1994 Jul; 301 ( Pt 2)(Pt 2):509-16. PubMed ID: 8042996
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High molecular weight non-immunoglobulin salivary agglutinins (NIA) bind C1Q globular heads and have the potential to activate the first complement component.
    Boackle RJ; Connor MH; Vesely J
    Mol Immunol; 1993 Feb; 30(3):309-19. PubMed ID: 8433709
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemical characterization and location of ionic interactions involved in the assembly of the C1 complex of human complement.
    Illy C; Thielens NM; Arlaud GJ
    J Protein Chem; 1993 Dec; 12(6):771-81. PubMed ID: 8136028
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural basis of the C1q/C1s interaction and its central role in assembly of the C1 complex of complement activation.
    Venkatraman Girija U; Gingras AR; Marshall JE; Panchal R; Sheikh MA; Harper JA; Gál P; Schwaeble WJ; Mitchell DA; Moody PC; Wallis R
    Proc Natl Acad Sci U S A; 2013 Aug; 110(34):13916-20. PubMed ID: 23922389
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beta-amyloid fibrils activate the C1 complex of complement under physiological conditions: evidence for a binding site for A beta on the C1q globular regions.
    Tacnet-Delorme P; Chevallier S; Arlaud GJ
    J Immunol; 2001 Dec; 167(11):6374-81. PubMed ID: 11714802
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Surfactant protein A regulates complement activation.
    Watford WT; Wright JR; Hester CG; Jiang H; Frank MM
    J Immunol; 2001 Dec; 167(11):6593-600. PubMed ID: 11714829
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A monoclonal antibody to C1q which appears to interact with C1r2C1s2-binding site.
    Hsiung L; Dodds AW; Mason DW; Reid KB
    FEBS Lett; 1988 Feb; 229(1):21-4. PubMed ID: 2831088
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibody-independent interaction between the first component of human complement, C1, and the outer membrane of Escherichia coli D31 m4.
    Aubert B; Chesne S; Arlaud GJ; Colomb MG
    Biochem J; 1985 Dec; 232(2):513-9. PubMed ID: 3911948
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rat polymeric IgA binds C1q, but does not activate C1.
    Hiemstra PS; Rits M; Gorter A; Stuurman ME; Hoekzema R; Bazin H; Vaerman JP; van Es LA; Daha MR
    Mol Immunol; 1990 Sep; 27(9):867-74. PubMed ID: 2215479
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural features of the first component of human complement, C1, as revealed by surface iodination.
    Villiers CL; Chesne S; Lacroix MB; Arlaud GJ; Colomb MG
    Biochem J; 1982 Apr; 203(1):185-91. PubMed ID: 6285892
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The distortive mechanism for the activation of complement component C1 supported by studies with a monoclonal antibody against the "arms" of C1q.
    Hoekzema R; Martens M; Brouwer MC; Hack CE
    Mol Immunol; 1988 May; 25(5):485-94. PubMed ID: 3261834
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The interaction of human plasma fibronectin with a subunit of the first component of complement, C1q.
    Pearlstein E; Sorvillo J; Gigli I
    J Immunol; 1982 May; 128(5):2036-9. PubMed ID: 6801128
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemistry and molecular genetics of C1q.
    Reid KB
    Behring Inst Mitt; 1989 Jul; (84):8-19. PubMed ID: 2679537
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A molecular mechanism for the activation of the first component of complement by immune complexes.
    Schumaker VN; Hanson DC; Kilchherr E; Phillips ML; Poon PH
    Mol Immunol; 1986 May; 23(5):557-65. PubMed ID: 3018553
    [TBL] [Abstract][Full Text] [Related]  

  • 19. C1 subcomponent complexes: basic and clinical aspects.
    Laurell AB; Sjöholm AG
    Behring Inst Mitt; 1993 Dec; (93):292-8. PubMed ID: 8172579
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Subunit interactions in the first component of complement, C1.
    Lakatos S
    Biochem Biophys Res Commun; 1987 Dec; 149(2):378-84. PubMed ID: 2827640
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.